Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019 – 2026

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019 – 2026

Chronic obstructive pulmonary disease (COPD) presents itself with mild, moderate, and severe symptoms. Treatment of chronic obstructive pulmonary disease (COPD) involves stepwise non-pharmacological and pharmacological interventions. Non-pharmacological interventions include risk reduction (smoking cessation) and preventing and treating co-morbidities (cardiovascular disease, anxiety, depression, and others). Pharmacological interventions include prescribing short acting bronchodilators, long acting bronchodilators, and others.

Market Dynamics

Factors such as awareness initiatives by organizations, increasing prevalence of COPD, and product launches is supporting the global chronic obstructive pulmonary disease (COPD) treatment market growth. For instance, in May 2019, Boehringer Ingelheim and Optimum Patient Care announced the creation of a new patient registry, APEX COPD, to better understand COPD and how it can be typically treated in primary care offices. Such initiatives by industry players are expected to boost global chronic obstructive pulmonary disease (COPD) treatment market over the forecast period. Moreover, pipeline for respiratory diseases and mainly COPD has several potential medications, which is expected to drive global chronic obstructive pulmonary disease (COPD) treatment market growth.

Key features of the study:

  • This report provides in-depth analysis of global chronic obstructive pulmonary disease (COPD) treatment market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global chronic obstructive pulmonary disease (COPD) treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include AstraZeneca Plc, Orion Corporation, Mylan N.V., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Novartis AG, Sunovion Pharmaceuticals, Inc., and CHIESI Farmaceutici SpA
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global chronic obstructive pulmonary disease (COPD) treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global chronic obstructive pulmonary disease (COPD) treatment market
Detailed Segmentation:
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Route of Administration:
  • Oral
  • Inhalation
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Region:
  • North America
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Class:
  • Bronchodilators
  • Beta 2-Agonists
  • Anticholinergics
  • Theophyllines
  • Phosphodiesterase Type 4 Inhibitors
  • Steroids
  • Others
  • By Route of Administration:
  • Oral
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • AstraZeneca Plc*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Orion Corporation
  • Mylan N.V.
  • Boehringer Ingelheim
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sunovion Pharmaceuticals, Inc.
  • CHIESI Farmaceutici SpA
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Key Highlights
Research and Development Collaboration, Mergers, and Acquisitions
PEST Analysis
Pipeline Analysis
Epidemiology
4. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Bronchodilators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Beta 2-Agonists
Anticholinergics
Theophyllines
Phosphodiesterase Type 4 Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Steroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
5. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Route of Administration, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Inhalation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Distribution Channel, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2018–2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Regions, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2026
North America
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country/Region, 2016–2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
GCC
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Company Profiles
AstraZeneca Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Orion Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boehringer Ingelheim
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sunovion Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
CHIESI Farmaceutici SpA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 32 figures on "Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook